K113181

Substantially Equivalent

CELLTRACKS ANALYER II

Applicant: Veridex, LLC
Product code: NQI
Advisory panel: Immunology
Date received: 2011-10-28
Decision date: 2011-12-12
Decision: Substantially Equivalent
Clearance type: Special
Location: Raritan, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.